RNA-sequencing of WFS1-deficient pancreatic islets

Physiological Reports

Volumn 4, Issue 7, 2016, Pages 1-12

  Ivask, Marilin ^a   Hugill, Alison ^b   Kõks, Sulev ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

Author keywords

Insulin; RNA sequencing; Trpm5; Wfs1

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; MEMBRANE PROTEIN; PROINSULIN; RNA; TOLBUTAMIDE; TRANSCRIPTOME; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM5 PROTEIN, MOUSE; WOLFRAMIN PROTEIN;

129 MOUSE; ANIMAL; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; HETEROZYGOTE; KNOCKOUT MOUSE; METABOLISM; PANCREAS ISLET; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SEQUENCE ANALYSIS; TISSUE CULTURE TECHNIQUE; WOLFRAM SYNDROME;

ANIMALS; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; HETEROZYGOTE; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MEMBRANE PROTEINS; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PROINSULIN; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SEQUENCE ANALYSIS, RNA; TISSUE CULTURE TECHNIQUES; TOLBUTAMIDE; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; TRPM CATION CHANNELS; WOLFRAM SYNDROME;

EID: 84962799486     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12750     Document Type: Article

References (38)

1. Ashcroft, F. M., and P. Rorsman . 1989. Electrophysiology of the pancreatic beta-cell. Prog. Biophys. Mol. Biol. 54:87-143.
2. Barrett, T. G., and S. E. Bundey . 1997. Wolfram (DIDMOAD) syndrome. J. Med. Genet. 34:838-841.
3. Brixel, L. R., M. K. Monteilh-Zoller, C. S. Ingenbrandt, A. Fleig, R. Penner, T. Enklaar, et al. 2010. TRPM5 regulates glucose-stimulated insulin secretion. Pflugers Arch. 460:69-76.
4. Cheurfa, N., G. M. Brenner, A. F. Reis, D. Dubois-Laforgue, R. Roussel, J. Tichet, et al. 2011. Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the data from epidemiological study on the insulin resistance syndrome (desir) prospective study. Diabetologia 54:554-562.
5. Colsoul, B., A. Schraenen, K. Lemaire, R. Quintens, L. Van Lommel, A. Segal, et al. 2010. Loss of high-frequency glucose-induced Ca2 + oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5-/- mice. Proc. Natl Acad. Sci. USA 107:5208-5213.
6. Cryns, K., T. A. Sivakumaran, J. M. Van den Ouweland, R. J. Pennings, C. W. Cremers, K. Flothmann, et al. 2003. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum. Mutat. 22:275-287.
7. Eizirik, D. L., M. Sammeth, T. Bouckenooghe, G. Bottu, G. Sisino, M. Igoillo-Esteve, et al. 2012. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 8:e1002552.
8. Florez, J. C., K. A. Jablonski, J. McAteer, M. S. Sandhu, N. J. Wareham, I. Barroso, et al. 2008. Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia 51:451-457.
9. Fonseca, S. G., M. Fukuma, K. L. Lipson, L. X. Nguyen, J. R. Allen, Y. Oka, et al. 2005. WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells. J. Biol. Chem. 280:39609-39615.
10. Fonseca, S. G., S. Ishigaki, C. M. Oslowski, S. Lu, K. L. Lipson, R. Ghosh, et al. 2010. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J. Clin. Invest. 120:744-755.
11. Franks, P. W., O. Rolandsson, S. L. Debenham, K. A. Fawcett, F. Payne, C. Dina, et al. 2008. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia 51:458-463.
12. Hatanaka, M., K. Tanabe, A. Yanai, Y. Ohta, M. Kondo, M. Akiyama, et al. 2011. Wolfram syndrome 1 gene (WFS1) product localizes to secretory granules and determines granule acidification in pancreatic beta-cells. Hum. Mol. Genet. 20:1274-1284.
13. Henquin, J. C., M. Nenquin, M. A. Ravier, and A. Szollosi . 2009. Shortcomings of current models of glucose-induced insulin secretion. Diabetes Obes. Metab. 11(Suppl 4):168-179.
14. van Hoek, M., A. Dehghan, J. C. Witteman, C. M. van Duijn, A. G. Uitterlinden, B. A. Oostra, et al. 2008. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 57:3122-3128.
15. Hofmann, S., C. Philbrook, K. D. Gerbitz, and M. F. Bauer . 2003. Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum. Mol. Genet. 12:2003-2012.
16. Inoue, H., Y. Tanizawa, J. Wasson, P. Behn, K. Kalidas, E. Bernal-Mizrachi, et al. 1998. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20:143-148.
17. Ishihara, H., S. Takeda, A. Tamura, R. Takahashi, S. Yamaguchi, D. Takei, et al. 2004. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum. Mol. Genet. 13:1159-1170.
18. Karasik, A., C. O'Hara, S. Srikanta, M. Swift, J. S. Soeldner, C. R. Kahn, et al. 1989. Genetically programmed selective islet beta-cell loss in diabetic subjects with Wolfram's syndrome. Diabetes Care 12:135-138.
19. Koks, S., U. Soomets, J. L. Paya-Cano, C. Fernandes, H. Luuk, M. Plaas, et al. 2009. Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway. Physiol. Genomics 37:249-259.
20. Ku, G. M., H. Kim, I. W. Vaughn, M. J. Hangauer, Oh C Myung, M. S. German, et al. 2012. Research resource: RNA-Seq reveals unique features of the pancreatic beta-cell transcriptome. Mol. Endocrinol. 26:1783-1792.
21. Luuk, H., S. Koks, M. Plaas, J. Hannibal, J. F. Rehfeld, and E. Vasar . 2008. Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome. J. Comp. Neurol. 509:642-660.
22. Luuk, H., M. Plaas, S. Raud, J. Innos, S. Sutt, H. Lasner, et al. 2009. Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behav. Brain Res. 198:334-345.
23. Minton, J. A., A. T. Hattersley, K. Owen, M. I. McCarthy, M. Walker, F. Latif, et al. 2002. Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes 51:1287-1290.
24. Moran, I., I. Akerman, M. van de Bunt, R. Xie, M. Benazra, T. Nammo, et al. 2012. Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 16:435-448.
25. Mortazavi, A., B. A. Williams, K. McCue, L. Schaeffer, and B. Wold . 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5:621-628.
26. Mykkanen, L., S. M. Haffner, C. N. Hales, T. Ronnemaa, and M. Laakso . 1997. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 46:1990-1995.
27. Noormets, K., S. Koks, M. Muldmaa, L. Mauring, E. Vasar, and V. Tillmann . 2011. Sex differences in the development of diabetes in mice with deleted wolframin (Wfs1) gene. Exp. Clin. Endocrinol. Diabetes 119:271-275.
28. Osman, A. A., M. Saito, C. Makepeace, M. A. Permutt, P. Schlesinger, and M. Mueckler . 2003. Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J. Biol. Chem. 278:52755-52762.
29. Philbrook, C., E. Fritz, and H. Weiher . 2005. Expressional and functional studies of Wolframin, the gene function deficient in Wolfram syndrome, in mice and patient cells. Exp. Gerontol. 40:671-678.
30. Prawitt, D., M. K. Monteilh-Zoller, L. Brixel, C. Spangenberg, B. Zabel, A. Fleig, et al. 2003. TRPM5 is a transient Ca2 + -activated cation channel responding to rapid changes in [Ca2 + ]i. Proc. Natl Acad. Sci. USA 100:15166-15171.
31. Riggs, A. C., E. Bernal-Mizrachi, M. Ohsugi, J. Wasson, S. Fatrai, C. Welling, et al. 2005. Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia 48:2313-2321.
32. Sandhu, M. S., M. N. Weedon, K. A. Fawcett, J. Wasson, S. L. Debenham, A. Daly, et al. 2007. Common variants in WFS1 confer risk of type 2 diabetes. Nat. Genet. 39:951-953.
33. Shimomura, K., J. Galvanovskis, M. Goldsworthy, A. Hugill, S. Kaizak, A. Lee, et al. 2009. Insulin secretion from beta-cells is affected by deletion of nicotinamide nucleotide transhydrogenase. Methods Enzymol. 457:451-480.
34. Strom, T. M., K. Hortnagel, S. Hofmann, F. Gekeler, C. Scharfe, W. Rabl, et al. 1998. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 7:2021-2028.
35. Takeda, K., H. Inoue, Y. Tanizawa, Y. Matsuzaki, J. Oba, Y. Watanabe, et al. 2001. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum. Mol. Genet. 10:477-484.
36. Takei, D., H. Ishihara, S. Yamaguchi, T. Yamada, A. Tamura, H. Katagiri, et al. 2006. WFS1 protein modulates the free Ca(2 + ) concentration in the endoplasmic reticulum. FEBS Lett. 580:5635-5640.
37. Terasmaa, A., U. Soomets, J. Oflijan, M. Punapart, M. Hansen, V. Matto, et al. 2011. Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin. J. Physiol. Biochem. 67:381-390.
38. Yamada, T., H. Ishihara, A. Tamura, R. Takahashi, S. Yamaguchi, D. Takei, et al. 2006. WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum. Mol. Genet. 15:1600-1609.